Alzheimer's Disease
From Proteopedia
(Difference between revisions)
| Line 31: | Line 31: | ||
***[[2wfz|Soman Complexed with Acetylcholinesterase]] or [[2wg0|Here]], or [[2wg1|Here]], or [[1cfj|Here]], or [[1som|Here]]. | ***[[2wfz|Soman Complexed with Acetylcholinesterase]] or [[2wg0|Here]], or [[2wg1|Here]], or [[1cfj|Here]], or [[1som|Here]]. | ||
***[[1acj|Tacrine Complexed with Acetylcholinesterase]] | ***[[1acj|Tacrine Complexed with Acetylcholinesterase]] | ||
| - | ** Bivalent Inhibitors | + | **Bivalent Inhibitors |
***[[1u65|Anticancer Prodrug CPT-11 Complexed with Acetylcholinesterase]] | ***[[1u65|Anticancer Prodrug CPT-11 Complexed with Acetylcholinesterase]] | ||
***[[1eve|Aricept Complexed with Acetylcholinesterase]] | ***[[1eve|Aricept Complexed with Acetylcholinesterase]] | ||
Revision as of 07:47, 27 September 2010
Alzheimer's Disease, is the most common form of dementia, especially in individuals over 65 years old. It is predicted to affect 1 in 85 people by 2050.
Articles in Proteopedia concerning Alzheimer's Disease include:
To view automatically seeded pages concerning Alzheimer's Disease See:
To view other Proteopedia pages about diseases & drug targets, See: Pharmaceutical Drug Targets
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Alexander Berchansky, Joel L. Sussman, Jaime Prilusky, Wayne Decatur
